Theraflu Cold Powder Recalled for Potential Foreign Substances
Novartis Consumer Health is recalling Theraflu Multi-Symptom Severe Cold powder packets because they may contain foreign substances.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically indicates a situation where use of the product could cause temporary or medically reversible adverse health consequences. The hazard is the presence of foreign substances, which is a moderate risk without specific reports of severe injury or death.
Plain-English summary
Novartis Consumer Health is recalling Theraflu Multi-Symptom Severe Cold powder packets in Green Tea & Honey Lemon flavors. The affected products contain acetaminophen, dextromethorphan hydrobromide, and phenylephrine hydrochloride and are packaged in 6-count cartons and 1-count cards.
The recall was initiated because the products may contain foreign substances. The affected units were distributed nationwide and in Mexico, Russia, Korea, Panama, China, and Canada.
Consumers should stop using the recalled products and contact Novartis Consumer Health for further instructions. The recall covers approximately 1.2 million cartons and cards across multiple lot numbers and expiration dates.
The recalled product
- Product
- THERAFLU (ACETAMINOPHEN, DEXTROMETHORPHAN HBR, PHENYLEPHRINE HCL)
- Brand
- THERAFLU
- Manufacturer
- Novartis Consumer Health
- Category
- Drug — OTC Cold Medicine
- Hazard
- Affected units
- 1,202,960
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (17)
- Lot #: a) 10116016
- Exp 6/30/2013
- 10118931
- Exp 7/31/2013
- 10121950
- Exp 8/31/2013
- 10122314
- 10122316
- 10124226
- Exp 9/30/2013
- 10124377
- 10124379
- 10125916
- 10128112
- 10128114
- Exp 10/31/2013
- b) 25872801
UPCs (2)
- 300676426068
- 300676426013
Distribution
Distributed nationwide across the United States.
Part of a larger recall action
This product is one of 16 recalled by Novartis Consumer Health under a single FDA (Drugs) recall action. The agency files each product separately, so the size of the action is not visible from this page alone.
See all 16 products in this recall →Related recalls
Same manufacturer · Novartis Consumer Health
See all →- ModerateNovartis Recalls Benefiber Fiber Supplement Stick Packs Due to Consumer Complaints
FDA (Food) · 2014-03-05
- ModerateNovartis Recalls Theraflu Severe Cold & Cough Powder Packets for Foreign Substances
FDA (Drugs) · 2014-01-29
- HighNovartis Recalls Theraflu Powder Packets Due to Foreign Substance Presence
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls NeoCitran Extra Strength Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
- ModerateNovartis Recalls Theraflu Exte Powder Packets Due to Foreign Substances
FDA (Drugs) · 2014-01-29
Same hazard · foreign substance
See all →- ModerateHeritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
FDA (Drugs) · 2026-08-19
- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01